ArticleFrontiers in immunology2023

Case report: Abolishing primary resistance to PD-1 blockade by short-term treatment of lenvatinib in a patient with advanced metastatic renal cell carcinoma.

Tingting Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.